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Abstract
Interleukin-6 (IL-6) is an important cytokine participating in multiple biologic activities in immune regulation and
inflammation. IL-6 has been associated with cardiovascular remodeling. However, the mechanism of IL-6 in hypertensive
cardiac fibrosis is still unclear. Angiotensin II (Ang II) infusion in mice increased IL-6 expression in the heart. IL-6 knockout (IL-
6-/-) reduced Ang II-induced cardiac fibrosis: 1) Masson trichrome staining showed that Ang II infusion significantly
increased fibrotic areas of the wild-type mouse heart,w h i c hw a sg r e a t l ys u p p r e s s e di nI L - 6 - / -m i c ea n d2 )
immunohistochemistry staining showed decreased expression of a-smooth muscle actin (a-SMA), transforming growth
factor b1 (TGF-b1) and collagen I in IL-6-/- mouse heart. The baseline mRNA expression of IL-6 in cardiac fibroblasts was low
and was absent in cardiomyocytes or macrophages; however, co-culture of cardiac fibroblasts with macrophages
significantly increased IL-6 production and expression of a-SMA and collagen I in fibroblasts. Moreover, TGF-b1 expression
and phosphorylation of TGF-b downstream signal Smad3 was stimulated by co-culture of macrophages with cardiac
fibroblasts, while IL-6 neutralizing antibody decreased TGF-b1 expression and Smad3 phosphorylation in co-culture of
macrophage and fibroblast. Taken together, our results indicate that macrophages stimulate cardiac fibroblasts to produce
IL-6, which leads to TGF-b1 production and Smad3 phosphorylation in cardiac fibroblasts and thus stimulates cardiac
fibrosis.
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Introduction
Hypertension is a multi-factorial chronic inflammatory disease.
It causes cardiac remodeling, characterized by fibrosis, inflamma-
tion and hypertrophy, and it is a major cause of heart failure [1].
Activation of the rennin-angiotensin system has an important role
in hypertension, cardiovascular remodeling [2,3]. Angiotensin II
(Ang II), a critical effector of this system has been implicated in the
development of hypertension-induced cardiac fibrosis and in-
flammation [4,5,6].
Inflammation is a key component in the myocardial remodeling
process that takes place in response to hypertension [1].
Interleukin-6 (IL-6) is a pleiotropic cytokine with a wide range of
biological activities in immune regulation, hematopoiesis, and
inflammation [7]. IL-6 produced by various cell types such as
vascular smooth muscle cells, macrophages, fibroblasts, endothe-
lial cells and lymphocytes, has pleiotropic effects on different organ
systems. Elevated IL-6 level is associated with heart failure and is
strongly prognostic of 1-year mortality [8].
A growing body of evidence suggests a close association of IL-6
level and hypertension in patients. Hirota et al. demonstrated that
concomitant overexpression of IL-6 and IL-6 receptor in mice
induce hypertrophy typical of that in hypertensive heart [9].
Giselleet et al. reported that IL-6 infusion cause myocardial
fibrosis, hypertrophy, and diastolic dysfunction in rats [10].
However, the role of endogenous IL-6 in hypertension-induced
myocardial fibrosis is unclear.
Transforming growth factor-b (TGF-b) has a pivotal role in
cardiac hypertrophy and cardiac fibrosis by activating fibroblasts
and producing collagen [11,12]. TGF-b has pleiotropic effects
predominantly through the intracellular mediators of TGF-
b signaling, Smads2/3. Upon receptor activation, Smad2/3 are
phosphorylated and form a heterotrimeric complex with Smad4
[13]. The interrelation between Ang II and TGF-b has been
established. In different pathological settings and cell types, Ang II
regulates TGF-b expression and activation, and the endogenous
production of TGF-b mediates some Ang II responses [14].
Macrophages trigger the differentiation of fibroblasts into
myofibroblasts within the infarct area after myocardial infarction,
mainly through TGF-b-dependent signaling [15]. Moreover,
TGF-b1-induced IL-6 expression participated in trans-differenti-
ation of fibroblasts to myofibroblasts [16]. In the myocardium,
activated myofibroblasts are the main source of extracellular
matrix proteins such as collagen I/III and fibronectin [17,18,19].
Here we aimed to study the role of IL-6 and its possible
mechanism in cardiac fibrosis induced by Ang II infusion. We
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5found IL-6 deficiency reduced Ang II-induced cardiac fibrosis. IL-
6 was mainly produced by cardiac fibroblasts by interaction with
macrophages. IL-6 stimulated TGF-b1 production and Smad3
phosphorylation, which promoted differentiation of cardiac
fibroblasts into myofibroblasts in vivo and in vitro.
Materials and Methods
Ethics Statement
Male IL-6-/- and wild-type (WT) mice in a C57BL/6
background were bred and maintained in the Laboratory of
Animal Experiments at Capital Medical University. The mice
were given a standard diet. The investigations conformed to the
US National Institutes of Health Guide for the Care and Use of
Laboratory Animals (publication no. 85-23, 1996) and were
approved by the Animal Care and Use Committee of Capital
Medical University.
Animal Models
IL-6 knockout (IL-6-/-) mice on a C57/B6 background mice
and wild-type (WT) littermates were purchased from the Jackson
Laboratory. All mice used for experiments were within 10 to 12
weeks of age and were maintained under specific-pathogen-free
conditions. The animals were handled according to the animal
welfare regulations of Capital Medical University, Beijing, and all
experimental procedures were approved by the Animal Subjects
Committee of Capital Medical University. Male mice were
randomly divided into 4 groups for treatment (n=6 each): WT
and IL-6-/-with saline infusion; WT and IL-6-/- with Ang II
infusion; Hypertensive cardiac fibrosis was induced in IL-6-/- and
WT mice by subcutaneous infusion of Ang II (Sigma-Aldrich, St.
Louis, MO), 1500 ng/kg/min, for 7 days via an osmotic
minipump (Alzet MODEL 1007D; DURECT, Cupertino, CA)
as we previously described [4,5,6,20,21]. Control animals received
saline infusion only. The mice were trained and Systolic blood
pressure was measured by the tail-cuff system (Softron BP98A;
Softron Tokyo, Japan). Data were derived from an average of 10–
20 measurements per animal at each time point.
Echocardiography
Transthoracic echocardiography was preformed on mice at day
7 after Ang II infusion. Briefly, mice were anesthetized using 3%
isoflurane and then moved to a biofeedback warming station that
measured heart rate, maintained core body temperature, and had
nose cone anesthesia (3% isoflurane). Ultrasound gel was placed
on the chest of the animal, and echocardiography measurements
were obtained using a 15-mHz probe for adults and the VEVO
770 software package (Visual Sonics). M-mode tracings were taken
and measured for posterior and anterior wall thicknesses, as well as
the interdimensional space for both systole and diastole. Ejection
fraction and fractional shortening were calculated as previously
described [6,22]. An average of three to five cardiac cycles per
animal were analyzed.
Histology and Immunohistochemistry
The ventricles were fixed in 4% paraformaldehyde and paraffin
embedded hearts were sectioned at 200 mm intervals from base to
apex, and serial sections of 4 mm were cut and placed on
polylysine-coated glass slides. Tissue sections were deparaffinized
and stained with Masson’s trichrome reagent. Immunohistochem-
istry involved use of a microwave-based antigen retrieval method.
After the inactivation of endogenous peroxides, sections were
incubated with antibodies against collagen I (Santa Cruz, 1:600
dilution), and a-smooth muscle actin (a-SMA; both 1:200 dilution,
Abcam, Cambridge, MA), Mac-2, IL-6 or TGF-b1 (all 1:200
dilution, Santa Cruz Biotechnology, Santa Cruz, CA) [23]. An
irrelevant isotype rabbit or goat Ig G was used as a negative
control (1:200 dilution, eBioscience, CA). Digital photographs
were taken at 400X magnification for more than 20 random fields
from each section, and positive areas were calculated by use of
NIS-ELEMENTS quantitative automatic program (NIKON,
Japan) in double-blind fashion. The positive area was thresholded
as a region of interest (ROI) using the hue-saturation intensity
color model in the Set Color Threshold subroutine to establish the
hue range of brown-stained positive to be accepted for analysis.
The area of the thresholded collagen ROI was defined as the
inclusive region for measurement. The area of the remaining
cardiac tissue was measured as the exclusive ROI in the tissue
section. The area of positive area and area of cardiac tissue in the
section were recorded using the Show Regions Statistics sub-
routine. The percentage of positive area present in the section was
determined by the ratio of inclusive area (I) of the blue-stained
ROI and the exclusive area (E) of the red stained cardiac tissue
ROI times 100 (% positive area [I/E] 100).
Serial transverse cryosections (7 mm thick) of frozen hearts were
cut at 220uC by use of a CM1950 Frigocut (Leica, Wetzlar,
Germany), placed on polylysine-coated glass slides, and stored at
280uC. Immunofluorescence with frozen hearts, 3-D frozen slices
or cell-seeded samples (described below) were incubated with the
primary antibodies against IL-6, DDR2 or TGF-b1 (both 1:200
dilution, Santa Cruz Biotechnology, Santa Cruz, CA), a-SMA,
F4/80 (both 1:200 dilution, Abcam, Cambridge, MA), p-Smad3
(1:200 dilution, Cell Signaling, Danvers, MA) and at 4uC
overnight, followed by incubation with secondary antibody which
are 488-donkey anti-goat and cy3-donkey anti-goat(both 1:500
dilution, Beyotime Biotechnology, China), PE-chicken anti-rat
(1:500 dilution, Santa Cruz Biotechnology, Santa Cruz, CA),
FITC-donkey anti-rabbit and 555-donkey anti-rabbit (both 1:500
dilution, Santa Cruz Biotechnology, Santa Cruz, CA) and nuclei
were counterstained with DAPI (blue). An irrelevant isotype rabbit
or goat Ig G was used as a negative control (Figure S2).
Macrophage Culture
Isolation of mouse peritoneal macrophages was as described
[24]. In brief, macrophages were obtained from mice by peritoneal
lavage 3 days after intraperitoneal injection with 1.5 ml sterile 3%
thioglycollate. Cells were cultured in DMEM supplemented with
10% fetal bovine serum, and 100 U/ml penicillin and 100 mg/ml
streptomycin. Non-adherent cells were removed after 4 h, and the
medium was replaced with fresh medium every 2 days [25].
Preparation of Primary Neonatal Cardiac Fibroblasts
Cardiac fibroblasts were isolated from neonatal IL-6-/- or WT
mice (1–2 days old). Briefly, excised hearts were washed in ice-cold
16phosphate buffer saline (16PBS) solution, and then ventricular
tissues were minced into small pieces by use of scissors in a mixture
of 0.2% collagenase type 2 and 0.25% trypsin. Minced tissue was
then placed into a sterile 50-ml tube and incubated with agitation
at 37uC for 50 min. The supernatant was collected, and the
remaining tissue was immersed in digestion solution. The super-
natants were pooled and filtered through a 400-mm nylon mesh
filter, then centrifuged at 1,000 g for 5 min at 4uC. The
supernatant was removed, and cells were placed into fibroblast
culture media (DMEM, 10% normal bovine serum and 100 U/ml
penicillin/streptomycin) and incubated for 2 h at 37uC with 5%
CO2 and 95% air. Cells were examined for positivity for vimentin.
Fibroblasts between passages 6 to 12 were used for experiments.
IL-6 Deficiency Prevents Cardiac Inflammation
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue | e35144 5RNA Extraction and Real-time PCR Analysis
Total RNAs were Trizol extracted from macrophages or
cardiac fibroblast isolated from IL-6-/- or WT age-matched mice
according to the manufacture’s protocol (Invitrogen, Carlsbad,
CA). Two micrograms of RNA was reversed transcribed by use of
the MMLV and oligo dT primer method (Invitrogen). Real-time
quantitative PCR reactions involved use of SYBR Green I
(Takara, Otsu, Shiga, Japan). PCR amplification was performed
on iQ5 Real-Time PCR Detection System (Bio-Rad, Hercules,
CA) with SYBR Green JumpStart
TM Taq ReadyMix
TM (Takara,
Otsu, Shiga, Japan) and specific primers for mouse IL-6, collagen
I, a-SMA [4]. The housekeeping gene GAPDH or 18S RNA was
used as a control. Oligo nucleotide primer sequences for each gene
studied were given in Table 1.
3-D Peptide Gel Co-culture
3-D peptide gel co-culture was as described [26] with
modification. Peritoneal macrophages and cardiac fibroblasts
were isolated and washed with 16PBS twice, then mixed at
a ratio of 1:1 in peptide gel at a final collagen concentration of
1.3 mg/ml. Peptide gel co-culture was maintained in DMEM
containing 10% fetal bovine serum at 37uC in a humidified
atmosphere containing 5% CO2 for 48 h. To detect the effect of
IL-6 on collagen synthesis, fibroblasts and macrophages isolated
from WT mice were plated on 48-well plates, serum starved for
24 h, then stimulated with IL-6 neutralizing antibody
(eBioscience, San Diego, CA) at 10 mg/ml or recombinant IL-6
(rIL-6, R&D Systems) at 25 ng/ml for 48 h.
Cytokine Analysis
To determine the production of cytokine in macrophages and
fibroblasts, cells were plated at 1610
5 per well in 24-well plates
and cultured for 48 h [27]. After incubation, the media was
collected and analyzed by use of Luminex (FLEXMAP 3D) and
the MILLIPLEX
TM Mouse Cytokine/Chemokine kit (Millipore,
Billerica, MA) to measure levels of IL-6.
Western Blot Analysis
Fresh tissues or cells were lysed with lysis buffer (20 mM
Tris(pH 7.5),1 mM EDTA,150 mM NaCl, 1 mM EGTA, 1 mM
b–glycerophosphate,1% Triton X-100, 2.5 mM sodium pyropho-
sphate,1 mM Na3VO4,4mg/ml aprotinin, 4 mg/ml leupeptin,
4 mg/ml pepstatin, and 1 mM PMSF). Protein samples were
separated by 10% SDS-PAGE. Nonspecific proteins were blocked
by incubating the membrane with 5% nonfat dried milk in Tris-
buffer saline containing 0.1% Tween 20 (TBS-T) for 1 h at room
temperature with agitation. Then the nitrocellulose membrane
was incubated with the primary antibodies anti-GAPDH (1:5000
diluted in TBS-T, Kangwei, China), anti-a-SMA (1:1000 dilution,
Abcam), anti-p-Smad3 or anti-TGF-b1 (both 1:1000 dilution,
Santa Cruz Biotechnology), then with IR Dye-conjugated
secondary antibodies (1:5000, Rockland Immunochemicals, Gil-
bertsville, PA) for 1 h. Images were quantified by use of the
Odyssey infrared imaging system (LI-COR Biosciences Lincoln,
NE). The protein contents were normalized to the level of
GAPDH. All experiments were repeated 3 times.
Statistical Analysis
Data are expressed as mean 6 SEM. Differences between
groups were analyzed by Student’s t test or ANOVA, then
Newman-Keuls Multiple Comparison Test by using Graphpad
Software (GraphPad Prism version 5.0 for windows, Graphpad
Software). P,0.05 was considered statistically significant.
Results
Increased IL-6 Expression in Ang II-induced Cardiac
Fibrosis
To establish the role of IL-6 in the development of Ang II–
induced cardiac remodeling, WT mice were infused with Ang
II, at 1500 ng/kg/min for 7 days [5,6,20,21], and IL-6
expression in myocardium was determined by immunohisto-
chemistry and western blot analysis. Ang II infusion significantly
increased IL-6 expression in the myocardium as compared with
saline infusion controls (Figure 1A and B). As well, Ang II
infusion elevated systolic blood pressure in both WT and IL-
6-/- groups as compared with saline-treated mice, with no
difference between WT and IL-6-/- mice (Figure 1C) [20]. The
2 experimental groups did not differ in cardiac function
characterized by left ventricular ejection fraction (Figure 1C)
and fractional shortening or ratio of heart to body weight or
after Ang II infusion (Figure S1), which indicated that IL-6
expression deficiency did not affect blood pressure or heart
function after a short time period Ang II infusion (at day 7).
IL-6 Deficiency Decreases Cardiac Fibrosis
Because inflammation plays an important role in myocardial
remodeling in response to hypertension and exogenous IL-6
may cause myocardial fibrosis [10], we examined the effect of
endogenous IL-6 on Ang II-induced cardiac fibrosis. Masson
trichrome staining showed fibrotic areas were significantly
greater in WT than IL-6-/- hearts with Ang II infusion
(Figure 2A). Western blot detected protein levels of transforming
growth factor b1 (TGF-b1) and a-smooth muscle actin (a-SMA)
were significantly greater in WT than IL-6-/- hearts with Ang
II infusion (Figure 2B). Immunohistochemistry confirmed the
expression of collagen I, a major component of fibrotic lesions;
TGF-b1, a pro-fibrotic cytokine; and a-SMA, a marker of
differentiation of fibroblasts into myofibroblasts, were all
markedly lower in IL-6-/- mice than that of in WT mice after
Table 1. Primer sequence for Real time-PCR and RT-PCR.
mRNA Forwards Rewards
IL-6 59-CTTCCATCCAGTTGCCTTCTTG-39 59-AATTAAGCCTCCGACTTGTGAAG-39
a-SMA 59-GCAAACAGGAATACGACGAAGC-39 59-GCTTTGGGCAGGAATGATTTG-39
collagen I 59-GAGCGGAGAGTACTGGATCG-39 59-TACTCGAACGGGAATCCATC-39
GAPDH 59-CCTGGAGAAACCTGCCAAGTATGA-39 59-AAGCAGGAATGAGAAGAGGCTGAG-39
18S 59-GGAAGTGCACCACCAGGAGT-39 59-TGCAGCCCCGGACATCTAAG-39
doi:10.1371/journal.pone.0035144.t001
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a critical role in cardiac fibrosis in response to Ang II infusion.
The number of the macrophage cell marker Mac-2 positive cells
was lower in IL-6-/- than WT mice with Ang II infusion
(Figure 2D), suggesting IL-6 deficiency decreased inflammation
and cardiac fibrosis induced by Ang II.
IL-6 is Mainly Produced by Cardiac Fibroblasts in
Response to Ang II Stimulation
We next evaluated the cellular source of IL-6 in Ang II-
induced cardiac fibrosis. Cardiomyocytes, macrophages, or
fibroblasts derived from WT mouse heart were treated with
Ang II (100 nmol/L) for various time (0,1,4,12 h respectively).
RT-PCR revealed the IL-6 expression was primarily present in
cardiac fibroblasts (Figure 3A). Furthermore, immunofluores-
cence revealed significantly greater IL-6 level in a-SMA–positive
myofibroblasts (Figure 3B) than that in F4/80-positive macro-
phages with Ang II treatment (Figure S3). Luminex analysis
showed that either cardiac fibroblasts or macrophages alone
produce low level IL-6 (less than 100 pg/ml of supernatant at
48 h, Figure 3C, left panel), however when cardiac fibroblasts
and macrophages were co-cultured together, IL-6 production
were significantly increased by 10.5 folds compared to
macrophages or cardiac fibroblasts alone (Figure 3C, right
panel). Importantly, co-culture of WT macrophages with IL-6-/-
cardiac fibroblasts produced very low amounts of IL-6, but co-
culture of IL-6-/- macrophages with WT cardiac fibroblasts was
still able to produce high level IL-6 (Figure 3C, right panel).
Therefore, endogenous IL-6 is mainly produced by cardiac
fibroblasts in a macrophage-dependent manner in response to
Ang II infusion.
IL-6 Promotes Cardiac Fibroblast Collagen Synthesis and
Fibroblast Activation in vitro
To delineate how endogenous IL-6 regulates cardiac fibrosis, we
next determined its role in fibroblast activation in a co-culture
system of cardiac fibroblasts and macrophages. The expression of
a-SMA (a marker of myofibroblasts) was examined in 3-D co-
culture of cardiac fibroblasts with macrophages stimulated by Ang
II. Cardiac fibroblasts or macrophages alone cultured in 3-D
peptide gel did not express a-SMA (Figure S4A), however, co-
culture of WT cardiac fibroblasts with IL-6 KO macrophages
stimulated a-SMA expression, whereas co-culture of IL-6 KO
cardiac fibroblasts with WT macrophages expressed very low-level
a-SMA expression (Figure 4A, top panel). Co-culture of WT
cardiac fibroblasts with macrophages stimulated a-SMA expres-
sion, whereas co-culture of IL-6 KO cardiac fibroblasts with
macrophages did not express a-SMA expression (Figure 4A,
middle panel). Treatment of co-culture of IL-6 KO cardiac
fibroblasts and macrophages with recombinant IL-6 restored the
expression of a-SMA while treatment of co-culture of WT cells
with neutralizing IL-6 antibody reduced the expression of a-SMA
(Figure 4A, lower panel). Real-time PCR revealed that co-culture
of cardiac fibroblasts with macrophages promoted the production
of a-SMA and collagen, indicating cardiac fibroblasts activation
was depended on macrophages (Figure 4B). Immunofluorescence
staining showed that IL-6 induced the phosphorylation of Smad3
and TGF-b1 expression. Immunofluorescence staining showed
that cultured WT fibroblasts and IL-6-/- fibroblasts alone almost
did not express phosphorylation of Smad3 and TGF-b1 (Figure
S4B). Administration of neutralizing antibody to IL-6 to the co-
culture of fibroblasts and macrophages, phosphorylation of Smad3
and TGF-b1 expression were reduced (Figure 4C, top panel).
Treatment of co-culture of IL-6 KO macrophages and cardiac
fibroblasts in 3-D peptide gels with IL-6 also increased
Figure 1. IL-6 production is increased in cardiac fibrosis induced by Ang II. (A) Immunohistochemical analysis of IL-6 production (brown) in
ventricles of mice (n=6 per group) after saline or Ang II infusion. (B) Western blot analysis for IL-6 expression in the hearts of WT mice. (C) Systolic
blood pressure (SBP) was measured and echocardiography was performed at day 7 after Ang II infusion. Error bars represent mean6SEM. *P,0.05;
***P,0.001. Scale bars: 50 mm.
doi:10.1371/journal.pone.0035144.g001
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lower panel). Finally, western blot analysis verified IL-6 stimulated
the phosphorylation of Smad3 and TGF-b1 expression
(Figure 4D).
Discussion
Both experimental studies and epidemiology showed that the
inflammatory response plays a critical role in hypertension-
induced cardiac remodeling. However, the relative importance
Figure 2. IL-6 promotes Ang II-induced cardiac fibrosis and inflammation. (A) Ang II-induced hypertensive cardiac fibrosis in C57BL/6 wild-
type (WT) and IL-6-/- mice (n=6 per group). (Left) Masson’s trichrome staining (blue) of ventricular sections analyzed for fibrotic areas at day 7 after
Ang II infusion (n=6 mice/group). Scale bars: 500 mm (top), 100 mm (bottom). Fibrotic area is stained blue. (Right) Quantification of fibrotic areas. (B)
Western blot analysis and quantification of protein levels of transforming growth factor b1 (TGF-b1) and a-smooth muscle actin (a-SMA) in WT and IL-
6-/- hearts (n=6 per group). Normalization is to GAPDH level. (C) Representative immunohistochemical staining of collagen I, TGF-b1 and a-SMA in
WT and IL-6-/- hearts. Scale bars: 50 mm and quantification (right). (D) Immunohistochemical staining and quantification of Mac-2 in WT and IL-6-/-
hearts. Scale bars: 50 mm. Data represent the mean6SEM (n=5 per group). *P,0.05; **P,0.01; ***P,0.001.
doi:10.1371/journal.pone.0035144.g002
Figure 3. Generation of inflammatory factors and localization of IL-6 in macrophages or myofibroblasts in Ang II-infused mice. (A)
RT-PCR analysis of mRNA expression of IL-6 in WT mice macrophages, cardiomyocytes and cardiac fibroblasts with Ang II treatment at 0,1,4,12 h
respectively. *P,0.05 vs. macrophages. (B) IL-6 (green) was detected in WT hearts and in myofibroblasts (red) in Ang II-treated hearts. Nuclei are DAPI
stained (blue; right). (C) Macrophages (Mw) were co-cultured with cardiac fibroblasts (CF), and the level of IL-6 production in the medium was
measured by luminex assay (n=5 per group). *P,0.05; ND: no detective; **P,0.01 vs. WT macrophages (Mw(WT)) and cardiac fibroblasts(CF(WT));
**P,0.01 vs. Mw(WT)+cardiac fibroblasts CF(IL-6-/-) and Mw(IL-6-/-)+CF(IL-6-/-).
doi:10.1371/journal.pone.0035144.g003
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PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e35144Figure 4. Co-culture of macrophages and myofibroblasts induces a-SMA, TGF-b1 and Smad3 expression. (A) Representative
immunohistochemical staining of a-SMA with 3-D co-culture in the present of Ang II. Scale bars: 50 mm. (B) Real-time PCR quantification of a-SMA
and TGF-b1 mRNA expression. (C) Immunofluorescence staining of protein level of phosphorylated Smad3 (p-Smad3; green) and DDR2 (red) or
Immunofluorescence staining of TGF-b1 (green) and DDR2 (red) in co-cultured WT macrophages and fibroblasts with neutralizing antibody to IL-6
and co-cultured IL-6-/- macrophages and fibroblasts with recombinant IL-6 (rIL-6) treatment. Scale bars: 50 mm. (n=6 per group). (D) Western blot
analysis and quantification of protein level of TGF-b1 and p-Smad3 in 3-D co-culture (n=4 per group). *P,0.05.
doi:10.1371/journal.pone.0035144.g004
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be fully elucidated. We studied the role of IL-6 in cardiac fibrosis
induced by Ang II infusion in mice. Ang II infusion increased IL-6
expression in hearts of mice, and IL-6 was mainly produced by
cardiac fibroblasts through interaction with macrophages. Mac-
rophage-stimulated cardiac-fibroblast production of IL-6 induced
TGF-b1 production and Smad3 phosphorylation in cardiac
fibroblasts, which promoted the differentiation of cardiac fibro-
blasts into myofibroblasts in vivo and in vitro. Finally, IL-6 deficiency
reduced Ang II-induced cardiac inflammation and fibrosis.
Clinical trials demonstrated a correlation of increased levels of
circulating IL-6 in patients and heart failure severity and mortality
[8]. IL-6 directly mediated myocardial fibrosis, hypertrophy, and
diastolic dysfunction [10]. However, the role of endogenous IL-6
in hypertension-induced cardiac fibrosis was unclear, and the cell
type producing IL-6 was unknown. We showed that Ang II
infusion significantly increased IL-6 expression in the myocardium
(Figure 1). It has been shown that IL-6 directly mediated
myocardial fibrosis by inducing a conversion in fibroblast
phenotype to myofibroblasts [10]. Cardiac fibroblasts stimulated
with Ang II were found to secrete members of the IL-6 family,
including IL-6 itself, which induced cardiomyocyte hypertrophy
[28]. We found that in the WT heart, Ang II infusion significantly
increased the fibrotic area, which was greatly suppressed in IL-6-/-
mice (Figure 2). Immunohistochemistry revealed the expression of
collagen I, a major component of fibrotic lesions; TGF-b1, a pro-
fibrotic cytokine; and a-SMA, a marker of differentiation of
fibroblasts into myofibroblasts, all markedly decreased in IL-6-/-
mice (Figure 2C), which suggests that endogenous IL-6 plays
a critical role in cardiac fibrosis in response to Ang II infusion.
Concurrently, the level of the inflammatory cell marker Mac-2 was
greatly reduced in IL-6-/- mice (Figure 2D), indicating that IL-6
deficiency decreases inflammation and cardiac fibrosis induced by
Ang II. Even though Ang II infusion for 7 days induced IL-6,
TGF-b1, collagen I and fibrosis in the heart (Figure 2), but did no
change blood pressure or cardiac function (Figure 1C). Our results
are consistent with other studies that have shown that knockout of
IL-6 do not change Ang II-induced blood pressure increases
[20,29]. Several studies have shown that long term Ang II infusion
(over 4 weeks,) caused cardiac hypertrophy, remodeling and
cardiac dysfunction in mice [30,31], however, short term infusion
of Ang II infusion (7 days) was not enough to cause cardiomyocyte
hypertrophy thus cardiac dysfunction, but instead, caused cardiac
inflammation. IL-6 is produced by various cell types such as
vascular smooth muscle cells, macrophages, fibroblasts, endothe-
lial cells or lymphocytes, and has pleiotropic effects on different
organ systems [32]. The diversity of IL-6–dependent effects is
widespread. Elevated IL-6 serum levels have been detected in
acute and chronic inflammation, and IL-6 directly induces cardiac
fibrosis, concentric hypertrophy, and diastolic dysfunction in rats
[10]. However, the cell type producing endogenous IL-6 in cardiac
remodeling was unclear. Immunofluorescence staining revealed
significantly greater IL-6 accumulation in a-SMA–positive myofi-
broblasts (Figure 3B) than in F4/80–positive macrophages in Ang
II-induced cardiac fibrosis in vivo (Figure S3). Moreover, in vitro
evidence showed that isolated cardiac fibroblasts expressed a low
level of IL-6 while macrophages or cardiomyocytes barely have
IL-6. IL-6 expression was significantly increased in cardiac
fibroblasts when WT or IL-6-/- macrophages were present,
however, there was very low IL-6 expression in IL-6-/- cardiac
fibroblasts even WT or IL-6-/- macrophages were present
(Figure 3C). Therefore, endogenous IL-6 is mainly produced by
cardiac fibroblasts in Ang II-induced cardiac fibrosis and it is
macrophage dependent.
Cardiac fibrosis is mediated in part by TGF-b1, a potent
stimulator of collagen-producing cardiac fibroblasts [11,33,34].
In cultured fibroblasts, TGF-b activates fibroblasts and induces
the production of growth factors, angiogenic factors, extracel-
lular matrix proteins, and proteases [35]. Macrophages trigger
the differentiation of fibroblasts into myofibroblasts within the
infarct area, mainly through TGF-b–dependent signaling in the
ischemic myocardium [15]. Our results showed the level of the
pro-fibrotic cytokine TGF-b1 markedly decreased in IL-6-/-
mice treated with Ang II, and rIL-6 increased TGF-b1
production (Figure 4). TGF-b1 has pleiotropic effects pre-
dominantly through intracellular mediators of TGF-b signaling
such as Smads2/3 [36]. Our results showed that IL-6 induced
the phosphorylation of Smad3 and TGF-b1 expression, which
was reduced with neutralizing IL-6 antibody. 3D co-culture
demonstrated that increased phosphorylation of Smad3 and a-
SMA expression was depended on IL-6, which suggests that
macrophages might have a synergetic role with IL-6 in
triggering the differentiation of cardiac fibroblasts into myofi-
broblasts, mediated in part by a TGF-b1/Smad3 pathway
(Figure 4). We showed in the present study that Ang II induces
IL-6 and fibrosis, which might be mediated in part by the TGF-
b1/Smad3 pathway, this conclusion is consistent with other
studies. Aoki et al. reported that there was an autocrine loop
between IL-6 and TGF-b1 through Smad2/3-dependent path-
ways in activated pancreatic stellate cells. Pancreatic stellate cells
express and secrete IL-6, while anti-TGF-b1 neutralizing
antibody blocked IL-6 secretion. Moreover, anti-IL-6 neutraliz-
ing antibody inhibited TGF-b1 secretion from PSCs [37]. In
another study, Zhang et al. showed that TGF-b1-stimulated
Smad-responsive promoter transcriptional activity was signifi-
cantly greater in the presence of IL-6 than that induced by
TGF-b1 alone. Augmented TGF-b1/Smad signaling following
the addition of IL-6 appeared to be mediated through binding
to the cognate IL-6 receptor [38].
In summary, IL-6 expression was increased in Ang II-infused
mouse heart, and IL-6 deficiency ameliorated cardiac inflamma-
tion and fibrosis. IL-6 is mainly produced by cardiac fibroblasts
with Ang II stimulation and is macrophage dependent; the
production induces collagen synthesis in cardiac fibroblasts and
promotes differentiation of fibroblasts into myofibroblasts in vivo
and in vitro. The pro-fibrotic effects of IL-6 might be mediated in
part by the TGF-b1/Smad3 pathway.
Supporting Information
Figure S1 Quantification of body weight and heart/
body weight from saline or Ang II infusion mice (n=6
per group). NS, no statistical significance. t test.
(TIF)
Figure S2 Negative antibody was replaced by control
IgG. (A) Representative immunohistochemical staining of IL-6
expression in WT mice with antibody aganist IL-6 or control IgG.
(B) Representative Immunohistochemical staining of a-SMA
expression in WT mice with antibody aganist a-SMA or control
IgG. Scale bars: 50 mm.
(TIF)
Figure S3 Immunofluorescence staining of IL-6 (green)
and F4/80 (red) expressions in Ang II-treated hearts of
WT mice. Scale bars: 50 mm.
(TIF)
Figure S4 Negative controls of Cultured macrophages
and myofibroblasts induce a-SMA, TGF-b1 and Smad3
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PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e35144expression. (A) Representative immunohistochemical staining of
a-SMA with 3-D system with WT or IL-6-/- macrophages and
WT or IL-6-/- fibroblasts in the present of Ang II. (B)
Immunofluorescence staining of protein level of phosphorylated
Smad3 (p-Smad3; green) and DDR2 (red) or Immunofluorescence
staining of TGF-b1 (green) and DDR2 (red) in cultured WT
fibroblasts and IL-6-/- fibroblasts. Scale bars: 50 mm. (n=6 per
group). Scale bars: 50 mm.
(TIF)
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